Clinical trial
Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
NCT00082173 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00082173 |
|---|---|
| Title | Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis |
| Official title | Phase 2 Randomized Trial of a Moxifloxacin-Containing Regimen For Treatment of Smear-Positive Pulmonary Tuberculosis in Adults With and Without HIV Infection |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Moxifloxacin |
| Enrollment | 170 |
| Start date | Oct 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | May 4, 2004 |
| Last update posted | May 22, 2013 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: